DK1063981T3 - Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader - Google Patents

Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader

Info

Publication number: DK1063981T3
Authority: DK; Denmark
Prior art keywords: desmethylselegiline; wounds; burns; treatment; selegiline
Prior art date: 1998-03-16

Application number

DK99911055T

Other languages

English (en)

Inventor

Mark G Resnick

Original Assignee

Somerset Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-16

Filing date

1999-03-03

Publication date

2002-10-14

1999-03-03 Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc

2002-10-14 Application granted granted Critical

2002-10-14 Publication of DK1063981T3 publication Critical patent/DK1063981T3/da

Links

208000027418 Wounds and injury Diseases 0.000 title abstract 3
UUFAJPMQSFXDFR-LLVKDONJSA-N Norselegiline Chemical compound C#CCN[C@H](C)CC1=CC=CC=C1 UUFAJPMQSFXDFR-LLVKDONJSA-N 0.000 title abstract 2
206010052428 Wound Diseases 0.000 title abstract 2
MEZLKOACVSPNER-GFCCVEGCSA-N selegiline Chemical compound C#CCN(C)[C@H](C)CC1=CC=CC=C1 MEZLKOACVSPNER-GFCCVEGCSA-N 0.000 title abstract 2
229960003946 selegiline Drugs 0.000 title abstract 2
230000006378 damage Effects 0.000 title 1
208000014674 injury Diseases 0.000 title 1
241001465754 Metazoa Species 0.000 abstract 1
206010051246 Photodermatosis Diseases 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

DK99911055T 1998-03-16 1999-03-03 Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader DK1063981T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7804398P	1998-03-16	1998-03-16
PCT/US1999/004588 WO1999047133A1 (en)	1998-03-16	1999-03-03	Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage

Publications (1)

Publication Number	Publication Date
DK1063981T3 true DK1063981T3 (da)	2002-10-14

Family

ID=22141568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99911055T DK1063981T3 (da)	1998-03-16	1999-03-03	Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader

Country Status (12)

Country	Link
US (3)	US6461619B1 (da)
EP (1)	EP1063981B1 (da)
CN (1)	CN1154484C (da)
AT (1)	ATE222101T1 (da)
AU (1)	AU750909B2 (da)
BR (1)	BR9908713A (da)
CA (1)	CA2322878C (da)
DE (1)	DE69902520T2 (da)
DK (1)	DK1063981T3 (da)
ES (1)	ES2178405T3 (da)
IL (2)	IL138290A0 (da)
WO (1)	WO1999047133A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6033682A (en)	1995-01-13	2000-03-07	Somerset Pharmaceuticals, Inc.	S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
CN1154484C (zh)	1998-03-16	2004-06-23	萨默塞特药品有限公司	司来吉兰或去甲基司吉兰在生产治疗创伤、烧伤、光照损害的药物中的用途
WO2002019964A2 (en) *	2000-08-28	2002-03-14	Somerset Pharmaceuticals, Inc.	Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
FR2813195B1 (fr) *	2000-08-29	2003-04-04	Serobiologiques Lab Sa	Utilisation d'extraits de la plante cassia alata dans des produits de soin
CN1620304B (zh) *	2001-12-18	2010-06-23	布拉西卡化学保护研究基金会股份有限公司	通过谷胱甘肽和ii型解毒酶预防和治疗氧化应激症
DE10229456A1 (de) *	2002-07-01	2004-02-05	Wank, Rudolf, Prof. Dr.med.	Verwendung von Dopamin-Rezeptor-Agonisten zur Behandlung von Hautgeschwülsten und Warzen
US20050276762A1 (en) *	2004-06-15	2005-12-15	Tapas Das	Topical compositions containing 5'-adenosine-diphosphate ribose
WO2006118246A1 (ja) *	2005-04-28	2006-11-09	Japan Science And Technology Agency	経皮吸収促進剤
EP1731143B1 (en) *	2005-06-06	2008-11-26	Nitto Denko Corporation	Percutaneous absorption-type pharmaceutical preparation using a metal chloride, preferably sodium chloride, for preventing cohesive failure
US20090324693A1 (en) *	2008-06-30	2009-12-31	Kimberly-Clark Worldwide, Inc.	Delivery Product for Topical Compositions
WO2012051374A2 (en) *	2010-10-15	2012-04-19	The Procter & Gamble Company	Use of monoamine oxidase inhibitors to improve epithelial biology
WO2012082950A2 (en) *	2010-12-14	2012-06-21	University Of Rochester	Chimeric fibronectin matrix mimetics and uses thereof
US9539201B2 (en)	2012-04-20	2017-01-10	KAT Transdermals LLC	Selegiline transdermal system
IT201800006455A1 (it) *	2018-06-19	2019-12-19		Nuovo utilizzo degli inibitori della monoammino ossidasi B

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0241809B1 (de)	1986-04-16	1990-08-08	ASTA Pharma Aktiengesellschaft	Synergistische Kombination von Amantadin und Selegilin
DE3779500T2 (de)	1986-06-10	1993-01-21	Chiesi Farma Spa	Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
US4861800A (en)	1987-08-18	1989-08-29	Buyske Donald A	Method for administering the drug deprenyl so as to minimize the danger of side effects
US4868218A (en)	1987-08-18	1989-09-19	Buyske Donald A	Method of treating depression
US5446070A (en)	1991-02-27	1995-08-29	Nover Pharmaceuticals, Inc.	Compositions and methods for topical administration of pharmaceutically active agents
GB8807504D0 (en)	1988-03-29	1988-05-05	Sandoz Ltd	Improvements in/relating to organic compounds
US4959205A (en) *	1989-03-23	1990-09-25	Collagen Corporation	Composition and method for treatment of dermal inflammation
US5190763A (en)	1990-05-07	1993-03-02	Alza Corporation	Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5192550A (en)	1990-05-07	1993-03-09	Alza Corporation	Dosage form for treating central nervous system disorders
US5221536A (en)	1990-05-07	1993-06-22	Alza Corporation	Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5057321A (en)	1990-06-13	1991-10-15	Alza Corporation	Dosage form comprising drug and maltodextrin
US5128145A (en)	1990-06-13	1992-07-07	Alza Corporation	Dosage form for Parkinson's disease, spasticity and muscle spasms
CA2039194C (en)	1990-08-31	1997-01-28	Norton W. Milgram	Uses of l-deprenyl and compositions for same
US5783606A (en) *	1995-02-10	1998-07-21	The University Of Toronto Innovations Foundation	Deprenyl compounds for treatment of glaucoma
HU209605B (en)	1991-04-15	1994-09-28	Chinoin Gyogyszer Es Vegyeszet	Process for production of wather-free transdermal preparation
US5266332A (en)	1991-12-06	1993-11-30	Alza Corporation	Method for administering anti-Parkinson drug
EP0593807A1 (en)	1992-10-22	1994-04-27	LTS Lohmann Therapie-Systeme GmbH & Co. KG	Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
US5242950A (en)	1992-04-23	1993-09-07	Somerset Pharmaceuticals, Inc.	Treatment of macular degeneration
US5354885A (en)	1992-12-24	1994-10-11	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Process for preparing ethyl ester of L-DOPA
FR2713087B1 (fr) *	1993-11-30	1996-02-23	Saurat Jean Hilaire	Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.
FR2728790B1 (fr) *	1994-12-29	1997-01-24	Cird Galderma	Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial
JP3036847B2 (ja) *	1995-01-13	2000-04-24	サマーセット・ファーマシューティカルズ・インコーポレイテッド	デスメチルセレギリンを用いる方法および医薬組成物
US6239181B1 (en) *	1996-03-15	2001-05-29	Somerset Pharmaceuticals, Inc.	Method for preventing and treating peripheral neurophathy by administering selegiline
US6262111B1 (en) *	1997-05-21	2001-07-17	Sloan-Kettering Institute For Cancer Research	Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US20020006913A1 (en) *	1997-11-04	2002-01-17	Von Borstel Reid W.	Antimutagenic compositions for treatment and prevention of photodamage to skin
CN1154484C (zh)	1998-03-16	2004-06-23	萨默塞特药品有限公司	司来吉兰或去甲基司吉兰在生产治疗创伤、烧伤、光照损害的药物中的用途

1999
- 1999-03-03 CN CNB998060755A patent/CN1154484C/zh not_active Expired - Fee Related
- 1999-03-03 AU AU29791/99A patent/AU750909B2/en not_active Ceased
- 1999-03-03 IL IL13829099A patent/IL138290A0/xx unknown
- 1999-03-03 CA CA002322878A patent/CA2322878C/en not_active Expired - Lifetime
- 1999-03-03 DK DK99911055T patent/DK1063981T3/da active
- 1999-03-03 ES ES99911055T patent/ES2178405T3/es not_active Expired - Lifetime
- 1999-03-03 AT AT99911055T patent/ATE222101T1/de not_active IP Right Cessation
- 1999-03-03 EP EP99911055A patent/EP1063981B1/en not_active Expired - Lifetime
- 1999-03-03 WO PCT/US1999/004588 patent/WO1999047133A1/en active IP Right Grant
- 1999-03-03 DE DE69902520T patent/DE69902520T2/de not_active Expired - Fee Related
- 1999-03-03 BR BR9908713-8A patent/BR9908713A/pt not_active Application Discontinuation
2000
- 2000-09-06 IL IL138290A patent/IL138290A/en not_active IP Right Cessation
- 2000-09-15 US US09/663,218 patent/US6461619B1/en not_active Expired - Fee Related
2002
- 2002-08-08 US US10/215,492 patent/US6709664B2/en not_active Expired - Fee Related
2004
- 2004-03-23 US US10/806,494 patent/US7147864B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU750909B2 (en)	2002-08-01
AU2979199A (en)	1999-10-11
WO1999047133A1 (en)	1999-09-23
HK1037980A1 (en)	2002-03-01
CN1154484C (zh)	2004-06-23
CA2322878C (en)	2008-05-06
BR9908713A (pt)	2000-11-21
US6461619B1 (en)	2002-10-08
DE69902520D1 (de)	2002-09-19
US7147864B2 (en)	2006-12-12
IL138290A (en)	2010-05-17
DE69902520T2 (de)	2003-04-10
EP1063981B1 (en)	2002-08-14
CA2322878A1 (en)	1999-09-23
IL138290A0 (en)	2001-10-31
US20040180009A1 (en)	2004-09-16
ATE222101T1 (de)	2002-08-15
CN1300209A (zh)	2001-06-20
EP1063981A1 (en)	2001-01-03
ES2178405T3 (es)	2002-12-16
US20030021833A1 (en)	2003-01-30
US6709664B2 (en)	2004-03-23

Publication	Publication Date	Title
DK1063981T3 (da)	2002-10-14	Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader
DK1294413T3 (da)	2004-08-30	Spröjtbare sammensætninger til sårpleje
CY1111912T1 (el)	2015-11-04	Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
DK0507190T3 (da)	1995-10-09	Midler med fysiologisk kølevirkning og til disse midler egnede aktive forbindelser
ATE270111T1 (de)	2004-07-15	Zusammensetzung und methode zur reduktion der toxizität von biologisch-aktiven faktoren
ATE311849T1 (de)	2005-12-15	Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
ATE212218T1 (de)	2002-02-15	Topische zusammensetzungen mit verbessertem hautgefühl
DE3483820D1 (de)	1991-02-07	Mittel zum reduzieren der ausbreitung des sebums.
TR200003113T2 (tr)	2001-05-21	3-(amino- veya aminoalkil) piridinon türevleri ve bunların HIV bağımlı hastalıkların tedavisinde kullanılması.
FR2777183B1 (fr)	2001-03-02	Utilisation d'au moins un hydroxystilbene dans une composition destinee a favoriser la desquamation de la peau et composition le comprenant
BRPI0414215A (pt)	2006-11-07	tienopirazóis
ATE197395T1 (de)	2000-11-11	Äusserlisches hautbehandlungsmittel
BR9903751A (pt)	2000-09-26	Composição para uso cosmético e/ou dermatológico, utilização cosmética da composição, utilização da composição e utilização de pelo menos um ácido aminossulfÈnico n-substituìdo
ES2186914T3 (es)	2003-05-16	Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
BG101126A (en)	1997-09-30	The use of muramylpeptide compounds
DK0700897T3 (da)	1999-02-01	L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
AR015956A1 (es)	2001-05-30	Composiciones de citoquinas oromucosales y usos de las mismas
ATE126058T1 (de)	1995-08-15	Dermatologische zusammensetzungen mit einem gehalt an cis-urocaninsäure.
DE60325529D1 (de)	2009-02-12	Verbesserung von Laserbehandlungen
DE69927260D1 (de)	2005-10-20	Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
DE69822276T2 (de)	2005-04-21	Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen
ES2187836T3 (es)	2003-06-16	Utilizacion de un extracto de terminalia catappa.
ATE185274T1 (de)	1999-10-15	Therapeutisches mittel gegen drohenden abortus
ES2185310T3 (es)	2003-04-16	Agente antivirico herbario.
KR920011502A (ko)	1992-07-24	인체 신경계의 통증을 치료할 수 있는 부자이중탕(附子理中湯)의 개량된 한방치료제 물질